We are live on ! Find out more
SSG

Summit Securities Group Portfolio holdings

AUM $1.05B
1-Year Est. Return 36.17%
This Fund
S&P 500
This Quarter Est. Return
-0.17%
1 Year Est. Return
+36.17%
3 Year Est. Return
+135.58%
5 Year Est. Return
+187.38%
10 Year Est. Return
+1,509.69%
AUM
$810M
AUM Growth
+$42.3M
Cap. Flow
+$35.7M
Cap. Flow %
4.41%
Top 10 Hldgs %
57.55%
Holding
1,465
New
478
Increased
97
Reduced
432
Closed
449

Top Buys

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$36.4M
2
NVDA icon
NVIDIA
NVDA
+$14.4M
3
IBM icon
IBM
IBM
+$13.7M
4
AVGO icon
Broadcom
AVGO
+$11.4M
5
AMZN icon
Amazon
AMZN
+$6.88M

Sector Composition

Rank Sector Weight
1 Technology 9.13%
2 Consumer Discretionary 2.07%
3 Industrials 1.71%
4 Materials 1.66%
5 Energy 1.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PCH
1126
DELISTED
PotlatchDeltic
PCH
-1,281
Closed -$51K
PDD icon
1127
CALL
Pinduoduo
PDD
$120B
-10,000
Closed -$1.13M
PDD icon
1128
Pinduoduo
PDD
$120B
-64,117
Closed -$7.27M
PENN icon
1129
PUT
PENN Entertainment
PENN
$2.53B
-15,000
Closed -$221K
PII icon
1130
Polaris
PII
$3.91B
-2,200
Closed -$139K
PLYM
1131
DELISTED
Plymouth Industrial REIT
PLYM
-2,000
Closed -$43.8K
PNFP icon
1132
Pinnacle Financial Partners Inc
PNFP
$16.2B
-721
Closed -$68.8K
PRDO icon
1133
Perdoceo Education
PRDO
$1.99B
-458
Closed -$13.4K
PRME icon
1134
CALL
Prime Medicine
PRME
$575M
-300
Closed -$1.04K
PSNY icon
1135
Polestar Automotive Holding UK
PSNY
$2B
-3
Closed -$64
PTGX icon
1136
CALL
Protagonist Therapeutics
PTGX
$9.8B
-3,100
Closed -$271K
PTGX icon
1137
Protagonist Therapeutics
PTGX
$9.8B
-500
Closed -$43.7K
QCOM icon
1138
Qualcomm
QCOM
$173B
-3,421
Closed -$585K
RCKT icon
1139
Rocket Pharmaceuticals
RCKT
$367M
-736
Closed -$2.58K
REVG
1140
DELISTED
REV Group
REVG
-5
Closed -$304
REW icon
1141
CALL
Proshares UltraShort Technology
REW
$3.67M
-9,450
Closed -$230K
REXR icon
1142
Rexford Industrial Realty
REXR
$8.12B
-600
Closed -$23.2K
REXR icon
1143
PUT
Rexford Industrial Realty
REXR
$8.12B
-600
Closed -$23.2K
RITM icon
1144
Rithm Capital
RITM
$5.79B
-7,600
Closed -$82.8K
RNAM
1145
DELISTED
Avidity Biosciences
RNAM
-4,000
Closed -$289K
RNAM
1146
PUT
DELISTED
Avidity Biosciences
RNAM
-25,000
Closed -$1.8M
ROAD icon
1147
Construction Partners
ROAD
$6.73B
-562
Closed -$61K
ROP icon
1148
Roper Technologies
ROP
$39.3B
-481
Closed -$214K
ROST icon
1149
Ross Stores
ROST
$78.6B
-979
Closed -$176K
RR icon
1150
Richtech Robotics
RR
$385M
-8,086
Closed -$26.1K

Similar funds

Summit Securities Group's Q1 2026 Portfolio in Review

As of Q1 2026, Summit Securities Group held 1,465 positions worth $810M, up 5.5% from $768M the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Summit Securities Group deployed $35.7M of net new capital in Q1 2026, opening 478 new positions and adding to 97 existing holdings. Its largest new stake was WIX.com: 20,000 shares worth $1.8M.

By sector, the portfolio is most concentrated in Technology at 9.1% of assets, down from 17% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was Global X Uranium ETF, an estimated $25.7M trimmed.

  • Summit Securities Group's largest Q1 2026 buy was WIX.com: 20,000 shares worth $1.8M.
  • Summit Securities Group added most to Invesco QQQ Trust in Q1 2026, an estimated $36.4M increase.
  • Summit Securities Group's biggest Q1 2026 reduction was Global X Uranium ETF, cutting an estimated $25.7M.
  • Summit Securities Group fully exited TSMC in Q1 2026, selling an estimated $53.8M.
  • Summit Securities Group's ten largest holdings make up 58% of its $810M portfolio in Q1 2026.
  • Summit Securities Group opened 478 new positions and closed 449 in Q1 2026.
  • Summit Securities Group's portfolio value rose 5.5% quarter-over-quarter to $810M.

Based on Summit Securities Group's 13F filing for Q1 2026, filed 30 Apr 2026.